Samsung Bioepis Boasts Positive Data On Lucentis And Herceptin Biosimilars

Post-Hoc Analysis And Five-Year Follow-Up Data Published By Firm

 
• By Dean Rudge
  
Business Conference Lectern Hands
Samsung Bioepis is to present the data at two virtual congresses • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products